56 participants
CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2022-12-23
- Start Date:
- 2019-03-08
- Completion:
- 2021-02-28
Conditions
- Advanced Renal Cell Carcinoma (All Subtypes)
- Metastatic Renal Cell Carcinoma (All Subtypes)
Interventions
- OTHER
No Results Yet